Southwest Research Institute recently broke ground on a new 21,000-square-foot Clinical Supply Facility to support government and industry clients with integrated pharmaceutical and bioengineering research and development.
 
“The new facility expands our bioengineering laboratory footprint and adds dedicated bioengineering production suites with filtered air and low airborne particulate counts,” said Darrel Johnston, director of SwRI’s Pharmaceutical and Bioengineering Department. “The Clinical Supply Facility will allow us to produce in vitro stem cells, certain types of vaccines and small molecule therapeutics in a clean environment at scales able to facilitate clinical trials for our clients.”
 
SwRI plays an important role in San Antonio’s highly collaborative biomedical ecosystem. As a pioneer in microencapsulation, bioengineering and pharmaceutical development, the Institute can assist clients with important research and development projects of all sizes, including small batches of therapeutics for rare diseases involving fewer than 200 units.
 
“The new pilot plant facility will provide three new Current Good Manufacturing Practices pilot plant suites and quality control labs all under one roof. This will improve workplace and regulatory efficiency to provide the space needed to serve more clients locally, nationally and internationally,” added Johnston.